U.S. market Closed. Opens in 6 hours 7 minutes

BLRX | BioLineRx Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue4.80MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A31.89M
Cost of Revenue4.63M654.00K702.00K934.00K940.00KN/AN/AN/AN/AN/AN/AN/AN/A7.21M
Gross Profit174.00K-654.00K-702.00K-934.00K-940.00KN/AN/AN/AN/AN/AN/AN/AN/A24.69M
Operating Expenses43.16M29.16M24.78M22.93M28.11M25.61M25.24M16.51M16.20M15.85M17.63M21.83M15.41M20.98M
Selling, General & Admin31.23M11.53M5.27M4.68M4.59M5.77M5.70M4.82M4.23M4.52M4.51M4.09M4.21M5.44M
Research & Development11.94M17.63M19.47M18.17M23.44M19.81M19.51M11.18M11.49M10.90M12.65M17.21M11.20M15.49M
Other Operating Expenses235.00K5.67M42.00K70.00K78.00K27.00K29.00K514.00K480.00K434.78K465.47K523.83K050.17K
Operating Income-42.99M-29.16M-24.78M-22.93M-28.11M-25.61M-25.24M-16.51M-16.20M-15.85M-17.63M-21.83M-15.41M3.70M
Other Expenses / Income-17.62M4.21M-2.28M-7.09M2.67M2.64M888.00K672.00K1.80M5.68M-15.79K1.42MN/A-1.61M
Before Tax Income-60.61M-24.95M-27.05M-30.02M-25.45M-22.96M-24.35M-15.84M-14.40M-10.17M-17.64M-20.42MN/A2.10M
Income Tax Expenses1.22M-6.08M1.09M911.00K1.36M-4.46M-888.00KN/AN/AN/AN/AN/AN/AN/A
Net Income-60.61M-18.87M-28.14M-30.93M-26.81M-18.51M-23.46M-15.84M-14.40M-10.17M-17.64M-20.42M-13.19M2.10M
Interest Expenses2.14M2.16M984.00K1.47M1.83M21.00K21.00K14.00K15.00K17.98K20.67K25.96K1.12M16.63K
Basic Shares Outstanding64.22M51.60M44.20M16.86M9.76M7.24M6.00M3.74M3.43M2.16M1.50M1.13M824.02K823.41K
Diluted Shares Outstanding64.22M51.60M44.20M16.86M9.76M7.24M6.00M3.74M3.43M2.16M1.50M1.13M824.02K830.31K
EBITDA-41.61M-22.14M-23.43M-22.34M-26.89M-26.85M-23.85M-16.48M-16.17M-15.84M-17.53M-21.81M-15.00M2.62M
EBITDA Margin-866.81%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%8.23%
EBIT-57.25M-22.79M-26.07M-28.55M-23.62M-22.94M-24.33M-15.83M-14.38M-10.16M-17.62M-20.39M-12.07M2.11M
EBIT Margin-1,192.79%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%6.63%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙